4-(1H-Imidazol-2-yl)aniline → 2-[4-(5-Chloro-2-cyanophenyl)-2-oxopyridin-1(2H)-yl]-N-[4-(1H-imidazol-2-yl)phenyl]propanamide
반응식
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:20]#[N:21])=[C:6]([C:8]2[CH:13]=[CH:12][N:11]([CH:14]([CH3:18])[C:15]([OH:17])=O)[C:10](=[O:19])[CH:9]=2)[CH:7]=1.[NH:22]1[CH:26]=[CH:25][N:24]=[C:23]1[C:27]1[CH:33]=[CH:32][C:30]([NH2:31])=[CH:29][CH:28]=1>>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:20]#[N:21])=[C:6]([C:8]2[CH:13]=[CH:12][N:11]([CH:14]([CH3:18])[C:15]([NH:31][C:30]3[CH:29]=[CH:28][C:27]([C:23]4[NH:24][CH:25]=[CH:26][N:22]=4)=[CH:33][CH:32]=3)=[O:17])[C:10](=[O:19])[CH:9]=2)[CH:7]=1참가 물질
3
실험 절차
71 mg (0.23 mmol) of 2-[4-(5-chloro-2-cyanophenyl)-2-oxopyridin-1(2H)-yl]propanoic acid (racemate) (Example 2.2B) and 40 mg (0.25 mmol) of 4-(1H-imidazol-2-yl)aniline (Example 1.2A) were reacted according to General Method 1. Yield: 4 mg (4% of theory)
출처 및 근거
- ORD 기록
- ord-7c0f58c09e934ee7bf0b99fbd62cae06
- 출처 데이터셋
- uspto-grants-2016_09